Arkadios Wealth Advisors Acquires 828 Shares of iShares Biotechnology ETF $IBB

Arkadios Wealth Advisors raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 13.6% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,917 shares of the financial services provider’s stock after acquiring an additional 828 shares during the quarter. Arkadios Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $875,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Ramirez Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the first quarter valued at $26,000. Berkshire Money Management Inc. purchased a new position in iShares Biotechnology ETF in the 2nd quarter worth about $28,000. Financial Gravity Asset Management Inc. bought a new stake in iShares Biotechnology ETF during the 1st quarter valued at about $30,000. Woodside Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 1st quarter valued at about $31,000. Finally, Harbor Asset Planning Inc. purchased a new stake in iShares Biotechnology ETF in the 2nd quarter valued at about $31,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.3%

Shares of NASDAQ:IBB opened at $159.38 on Monday. The firm’s 50 day simple moving average is $146.78 and its 200-day simple moving average is $134.41. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $159.79.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.